Lisha Wang

This inventor holds 36 USPTO granted patents and 7 published patent applications and 24 EPO patents, primarily in Virus Infection Treatment. Top assignees: Hoffmann-La Roche Inc., Chugai Seiyaku Kabushiki Kaisha, F. Hoffmann-La Roche Ag. Active years: 2013-2023.

USPTO Granted Patents = 36 (Patent Applications = 7)

% Patents Active = 75.0

EPO Patents = 24 (Patent Applications = 28)

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 105(Granted Patents)

Location History:

Basel, CH (2016 - 2021)
Riehen, CH (2016 - 2021)
Shanghai, CN (2013 - 2023)

Company Filing History:

34 out of 5,011

Hoffmann-La Roche Inc.

patents

2 out of 984

Chugai Seiyaku Kabushiki Kaisha

patents

2 out of 180

F. Hoffmann-La Roche Ag

patents

where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...

Areas of Expertise:

Respiratory Syncytial Virus

Aminothiazolopyrimidinediones

Benzazepine Compounds

Dihydropyrimidinyl

Aza-Oxo-Indoles

Pyrazolyl Compounds

Heteroaryldihydropyrimidines

Imidazoles

Dihydroquinoline

Carboxamide Compounds

Secondary Amide

Tertiary Amide

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49481 - Compounds for the treatment and prophylaxis of respiratory syncytial virus disease (2023-04-03),

2. 11180525 - Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infection (2021-11-23),

3. 11046671 - Dihydropyrimidinyl benzazepine carboxamide compounds (2021-06-29),

4. 10975098 - Substituted aminothiazolopyrimidinediones for the treatment of virus infection (2021-04-13),

5. 10913745 - Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors (2021-02-09),

6. 10849881 - Octahydro-cyclobuta[1,2-c;3,4-c']dipyrrol-2-yl (2020-12-01),

7. 10669268 - Bicyclic derivatives (2020-06-02),

8. 10618929 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection (2020-04-14),

9. 10590146 - Substituted aminothiazolopyrimidinediones (2020-03-17),

10. 10590112 - Dihydropyrimidinyl benzazepine carboxamide compounds (2020-03-17),

11. 10544102 - Benzazepine dicarboxamide compounds with secondary amide function (2020-01-28),

12. 10428027 - Sulfinylphenyl or sulfonimidoylphenyl benzazepines (2019-10-01),

13. 10370338 - Benzazepine dicarboxamide compounds with tertiary amide function (2019-08-06),

14. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection (2019-01-29),

15. 10065973 - Substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection (2018-09-04),

Title: The Innovative Journey of Inventor Lisha Wang

Introduction: Inventor Lisha Wang, a visionary based in Basel, Switzerland, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Lisha Wang's recent patents include cutting-edge advancements in artificial intelligence, renewable energy solutions, and sustainable transportation methods.

Career Highlights: With a career spanning over two decades, Lisha Wang has established himself as a pioneer in the tech industry, leading research and development teams to create revolutionary products that have reshaped the way we live and work.

Collaborations: Throughout his career, Lisha Wang has collaborated with top research institutions, leading companies, and brilliant minds from around the world, fostering a culture of innovation and excellence.

Conclusion: Lisha Wang's relentless pursuit of innovation and his passion for creating a better future through technology continue to inspire generations of inventors and entrepreneurs worldwide.